This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Messing, E. M. Articles by Reznikoff, C. A. Search for Related Content PubMed PubMed Citation Articles by Messing, E. M. Articles by Reznikoff, C. A.

Normal and Malignant Human Urothelium: In Vitro Effects of Epidermal Growth Factor¹

Departments of Surgery [E. M. M.] and Human Oncology [E. M. M., C. A. R.], University of Wisconsin School of Medicine, Madison, Wisconsin 53792

Cultures of human normal urothelial (HU) cells and transitional cell carcinoma (TCC) cell lines were tested for their ability to specifically bind and respond to epidermal growth factor (EGF). The criteria of response investigated were stimulation of growth and induction of ornithine decarboxylase (ODC) activity. All four human TCC cell lines tested were stimulated to grow by EGF (1-100 ng/ml) in a dose related fashion while only one of four HU cell cultures was similarly stimulated, and growth stimulation of this cell line occurred only at early passage. TCC and HU cells bound EGF to similar degrees with K_ds of 0.86 nM for TCC and 2.54 nM for HU (P > 0.05) and 91637 ± 9816 (SD) (high affinity) receptors/cell for TCC and 124275 ± 16841 for HU (P > 0.10). Baseline ODC activity was statistically similar in the two TCC and the three HU cell cultures tested. However, EGF induced dose related ODC activity only in the TCC cell lines and not in any of the HU cell cultures. Thus, while both malignant and normal urothelium bind EGF equally well in vitro, only TCC responds to EGF in two parameters relevant to neoplasia: growth and induction of ODC activity.

¹ Supported by grants R23-CA36908 (E. M. M.) and CA29525 (C. A. R.) from NIH.

² To whom requests for reprints should be addressed.

Received 9/25/86. Revised 1/20/87. Accepted 1/23/87.

This article has been cited by other articles:

				S. A. Bravo, C. U. Nielsen, J. Amstrup, S. Frokjaer, and B. Brodin Epidermal growth factor decreases PEPT2 transport capacity and expression in the rat kidney proximal tubule cell line SKPT0193 cl.2 Am J Physiol Renal Physiol, February 1, 2004; 286(2): F385 - F393. [Abstract] [Full Text] [PDF]

				C. U. Nielsen, J. Amstrup, B. Steffansen, S. Frokjaer, and B. Brodin Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G191 - G199. [Abstract] [Full Text] [PDF]

				A. E. Marjou, A. Delouvee, J. P. Thiery, and F. Radvanyi Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression Carcinogenesis, December 1, 2000; 21(12): 2211 - 2218. [Abstract] [Full Text] [PDF]

				E. M. Messing, R. R. Love, K. D. Tutsch, A. K. Verma, J. Douglas, M. Pomplun, R. Simsiman, and G. Wilding Low-Dose Difluoromethylornithine and Polyamine Levels in Human Prostate Tissue J Natl Cancer Inst, August 18, 1999; 91(16): 1416 - 1417. [Full Text] [PDF]

				S. T. Truschel, W. G. Ruiz, T. Shulman, J. Pilewski, T.-T. Sun, M. L. Zeidel, and G. Apodaca Primary Uroepithelial Cultures. A MODEL SYSTEM TO ANALYZE UMBRELLA CELL BARRIER FUNCTION J. Biol. Chem., May 21, 1999; 274(21): 15020 - 15029. [Abstract] [Full Text] [PDF]